FDA grants Eli Lilly's COVID-19 combination therapy emergency use authorization
INDIANAPOLIS -- The U.S. Food and Drug Administration granted emergency use authorization for Eli Lilly's combination therapy of bamlanivimab and etesevimab to treat COVID-19, Eli…
